Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid

被引:41
作者
Tsoumakidou, Maria
Tzanaki, Nikolaos
Papadaki, Helenia
Koutala, Heleni
Siafakas, Nikolaos M.
机构
[1] Univ Crete, Sch Med, Dept Thorac Med, Iraklion 71110, Crete, Greece
[2] Univ Crete, Sch Med, Dept Hematol, Iraklion, Crete, Greece
关键词
BDCA; bronchoalveolar lavage fluid; CD1a; dendritic cell; Langerhans cell;
D O I
10.1111/j.1440-1711.2006.01428.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Studies of bronchoalveolar lavage fluid (BALF) dendritic cells (DC) have been hampered by the scarcity of DC and the lack of DC-specific surface markers. Four surface Ag have been recently described as specific markers for distinct subsets of DC and have been used for the isolation and characterization of fresh noncultured DC from lung resection specimens: BDCA-1 (CD1c) and BDCA-3 for myeloid DC type 1 and type 2, respectively, and BDCA-2 and BDCA-4 for plasmacytoid DC. The aim of this study was to develop a new method for the isolation of BALF DC, using immunomagnetic separation of BDCA+ cells. Mononuclear cells were obtained from BALF after Ficoll-Paque density gradient centrifugation. Monocytes, T cells and B cells were magnetically labelled and depleted. The unlabelled cell fraction was incubated with BDCA-1, BDCA-3 and BDCA-4 beads and the total BDCA+ DC were retained. The ability of isolated DC to induce T-cell responses was evaluated by coculturing the isolated DC with immunomagnetically sorted naive T cells. The above procedure resulted in a population of viable DC that showed a strong capacity in induce T-cell responses. Functionally intact human BALF myeloid DC types 1 and 2 as well as plasmacytoid DC can be easily obtained by immunomagnetic isolation. Considering that bronchoalveolar lavage is a minimally invasive procedure, these cells are optimal candidates with which to elucidate the properties and capabilities of pulmonary DC.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 24 条
[1]   Origin and differentiation of dendritic cells [J].
Ardavín, C ;
del Hoyo, GM ;
Martín, P ;
Anjuère, F ;
Arias, CF ;
Marín, AR ;
Ruiz, S ;
Parrillas, V ;
Hernández, H .
TRENDS IN IMMUNOLOGY, 2001, 22 (12) :691-700
[2]   A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing [J].
Cella, M ;
Dohring, C ;
Samaridis, J ;
Dessing, M ;
Brockhaus, M ;
Lanzavecchia, A ;
Colonna, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (10) :1743-1751
[3]   Human lung dendritic cells have an immature phenotype with efficient mannose receptors [J].
Cochand, L ;
Isler, P ;
Songeon, F ;
Nicod, LP .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 21 (05) :547-554
[4]   Identification and characterization of human pulmonary dendritic cells [J].
Demedts, IK ;
Brusselle, GG ;
Vermaelen, KY ;
Pauwels, RA .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 32 (03) :177-184
[5]   Identification, rare-event detection and analysis of dendritic cell subsets in bronchoalveolar lavage fluid and peripheral blood by flow cytometry [J].
Donnenberg, VS ;
Donnenberg, AD .
FRONTIERS IN BIOSCIENCE, 2003, 8 :S1175-S1180
[6]   BDCA-2, BDCA-3 and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood [J].
Dzionek, A ;
Fuchs, A ;
Schmidt, P ;
Cremer, S ;
Zysk, M ;
Miltenyi, S ;
Buck, DW ;
Schmitz, J .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6037-6046
[7]   BDCA-2, a novel plasmacytoid dendritic cell-specific type IIC-type lectin, mediates antigen capture and is a potent inhibitor of interferon α/β induction [J].
Dzionek, A ;
Sohma, Y ;
Nagafune, J ;
Cella, M ;
Colonna, M ;
Facchetti, F ;
Günther, G ;
Johnston, I ;
Lanzavecchia, A ;
Nagasaka, T ;
Okada, T ;
Vermi, W ;
Winkels, G ;
Yamamoto, T ;
Zysk, M ;
Yamaguchi, Y ;
Schmitz, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (12) :1823-1834
[8]  
DZIONEK A, 2002, LEUKOCYTE TYPING, V7, P312
[9]   The role of dendritic cells in asthma [J].
Holt, Patrick G. ;
Upham, John W. .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 4 (01) :39-44
[10]  
Inoshima N, 2002, CLIN CANCER RES, V8, P3480